CONTRIBUTION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HOST-DEFENSE MECHANISM AGAINST CRYPTOCOCCUS-NEOFORMANS
Citation
K. Kawakami et al., CONTRIBUTION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HOST-DEFENSE MECHANISM AGAINST CRYPTOCOCCUS-NEOFORMANS, Clinical and experimental immunology, 106(3), 1996, pp. 468-474
Categorie Soggetti
Immunology
SICI code
0009-9104(1996)106:3<468:COT(IH>2.0.ZU;2-T
Abstract
We investigated the role of TNF-alpha in the host defence mechanism ag
ainst infection with a virulent strain of Cryptococcus neoformans. Adm
inistration of exogenous recombinant human TNF-alpha significantly pro
longed the survival time of mice infected by intratracheal instillatio
n of the organism. Surprisingly, neutralizing MoAb to murine TNF-alpha
did not shorten their survival time, a finding inconsistent with prev
ious results. To investigate the cause of this inconsistency, we exami
ned the production of TNF-alpha in the lungs of infected mice. During
the course of cryptococcosis, there was little or no generation of TNF
-alpha mRNA in the lung. This might be partly due to a direct inhibito
ry action of the fungal microorganism on TNF-alpha production by macro
phages. In vitro production of TNF-alpha by murine interferon-gamma (I
FN-gamma)- and lipopolysaccharide (LPS)-stimulated macrophages was str
ongly inhibited by co-culturing with the whole yeast cells. In contras
t, administration of recombinant murine IL-12 markedly induced TNF-alp
ha production and the neutralizing anti-TNF-alpha MoAb strongly blocke
d IL-12-induced protection of mice against cryptococcal infection. The
se results indicate that endogenously synthesized TNF-alpha has the po
tential to contribute to the elimination of C. neoformans and partly m
ediates the protective effect of IL-12.